Found 10 matching trials
Expanded Access Treatment of Subjects With Critical Limb Ischemia (CLI) With Minor Tissue Loss Who Are Unsuitable for Revascularization N/A A Phase III study of PLX-PAD for CLI patients with minor tissue loss who ar...
Show More Status
No Longer Available
Location
OBL-NJ Endovascular & Amputation Prevention, LLC,1429 Broad St., Clifton, NJ
Learn More & Join Trial
Efficacy, Tolerability and Safety of Intramuscular Injections of PLX PAD for the Treatment of Subjects With Critical Limb Ischemia (CLI) With Minor Tissue Loss Who Are Unsuitable for Revascularization PHASE3 This will be a randomized, placebo-controlled, parallel group, multicenter,...
Show More Location
UCI Medical Center 101 The City Drive S. Bldg 55 Rm 334 Orange, CA 92868
Learn More & Join Trial
Double-Blind, Multicenter, Study to Evaluate the Efficacy of PLX PAD for the Treatment of COVID-19 PHASE2 This clinical trial will examine if a new treatment of Mesenchymal-like Adh...
Show More Location
University of California Irvine
Learn More & Join Trial
Safety and Efficacy of IM Injections of PLX-PAD for the Regeneration of Injured Gluteal Musculature After Total Hip Arthroplasty PHASE1 Local administration of PLX-PAD single dose, intra-muscular injection for t...
Show More Location
Charité Universitätsmedizin Berlin
Learn More & Join Trial
Open-label Multicenter Study to Evaluate the Efficacy of PLX-PAD for the Treatment of COVID-19 PHASE2 This clinical trial will examine if a new treatment of Mesenchymal-like Adh...
Show More Location
Charite Campus Virchow
Learn More & Join Trial
Safety of Intramuscular Injection of Allogeneic PLX-PAD Cells for the Treatment of Critical Limb Ischemia PHASE1 The The purpose of this study is to determine the safety of PLX-PAD single ...
Show More Location
Franziskus-Krankenhaus
Learn More & Join Trial
Expanded Access for Treatment Use of PLX-PAD in Critical Limb Ischemia (CLI) N/A This is an Expanded Access program (EAP), sponsored by WideTrial for the tr...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Efficacy of Allogeneic Cells for the Treatment of Intermittent Claudication(IC) PHASE2 The objective of the study is to establish the safety profile of
Intramusc...
Show More Location
Cardiology, P. C. and Center for Therapeutic Angiogenesis
Learn More & Join Trial
Safety of Intramuscular Injections (IM) of Allogeneic PLX-PAD Cells for the Treatment of Critical Limb Ischemia (CLI) PHASE1 The purpose of this study is to determine the safety of PLX-PAD, Intra-musc...
Show More Learn More & Join Trial
Cellular Therapy for In Utero Repair of Myelomeningocele - The CuRe Trial PHASE1 Spina bifida, or myelomeningocele (MMC), is a birth defect that results in ...
Show More Learn More & Join Trial